We report that miR-410 is upregulated in colorectal cancer and hepatocarcinoma and that miR-410 can decrease FHL1 protein levels both directly by targeting the FHL1 3'UTR and indirectly by promoting the up-regulation of DNA methylases. This evidence concerns the gene FHL1 and colorectal cancer.